Advisory Committee on Immunization Practices (ACIP)

On November 5, 2021, this report was posted online as an MMWR Early Release.The Pfizer-BioNTech COVID-19 (BNT162b2) vaccine is a lipid nanoparticle–formulated, nucleoside-modified mRNA vaccine encoding the prefusion spike glycoprotein of…

On February 27, 2021, the Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for the adenovirus-vectored COVID-19 vaccine (Janssen Biotech, Inc., a Janssen Pharmaceutical company, Johnson & Johnson), and…

Tara C. Anderson, DVM, PhD1; Nina B. Masters, PhD1,2; Angela Guo, MPH, MBA1; Leah Shepersky, MPH1; Andrew J. Leidner, PhD3; Grace M. Lee, MD4; Camille N. Kotton, MD5; Kathleen L. Dooling, MD1 (View author affiliations) View suggested…

Evidence Pneumococcal disease incidence in adults. During 2018–2019, the incidence of all IPD in adults aged ≥65 years was 24 per 100,000 population (Figure), and PCV13 serotypes accounted for 27% of cases; additional serotypes unique…

Changes in the 2022 Adult Immunization Schedule Vaccine-specific changes in the 2022 immunization schedule for adults aged ≥19 years include new or updated ACIP recommendations for hepatitis B vaccine (HepB) (2), influenza vaccine (3),…

Methods During March 2020–November 2021, the Ebola Vaccine Work Group met at least monthly via conference call to review and discuss relevant evidence regarding expansion of recommendations to the two populations of interest using the…

Recommendations for Use of Moderna COVID-19 Vaccine During June 2020–February 2022, ACIP convened 23 public meetings to review data on the epidemiology of COVID-19 and considerations for use of all COVID-19 vaccines, including the…

Please note: This report has been corrected. Agam K. Rao, MD1; Deborah Briggs, PhD2; Susan M. Moore, PhD2; Florence Whitehill, DVM1,3; Doug Campos-Outcalt, MD4; Rebecca L. Morgan, PhD5; Ryan M. Wallace, DVM1; José R. Romero, MD6; Lynn…

Recommendations for the Use of the Moderna COVID-19 Vaccine in Children Aged 6 Months–5 Years and the Pfizer-BioNTech COVID-19 Vaccine in Children Aged 6 Months–4 Years Data reviewed with the EtR Framework supported the use of COVID-19…

Summary of Evidence for Use of the Novavax COVID-19 Vaccine in Persons Aged ≥18 Years The body of evidence regarding efficacy of the Novavax COVID-19 vaccine among persons aged ≥18 years consisted of data from one randomized,…

Recommendations for the Use of Influenza Vaccines, 2022–23 Groups Recommended for Vaccination Routine annual influenza vaccination is recommended for all persons aged ≥6 months who do not have contraindications. Recommendations…

Evidence Pneumococcal Disease Incidence in Persons Aged <19 Years Acute otitis media is one of the most common diagnoses associated with outpatient pediatric medical visits (8) and antibiotic prescribing (9). According to a recent…

Evidence Pneumococcal Disease Incidence in Persons Aged <19 Years Acute otitis media is one of the most common diagnoses associated with outpatient pediatric medical visits (8) and antibiotic prescribing (9). According to a recent…

Hannah G. Rosenblum, MD1; Megan Wallace, DrPH1; Monica Godfrey, MPH1; Lauren E. Roper, MPH1; Elisha Hall, PhD1; Katherine E. Fleming-Dutra, MD1; Ruth Link-Gelles, PhD1; Tamara Pilishvili, PhD1; Jennifer Williams, PhD1; Danielle L.…

Summary What is already known about this topic? Since 1978, M-M-R II has been the only measles, mumps, and rubella (MMR) combination vaccine used in the United States. In June 2022, the Food and Drug Administration licensed an…

Clinical Guidance Considerations in Choosing JYNNEOS or ACAM2000 for Primary Vaccination JYNNEOS involves a replication-deficient virus and has fewer contraindications, no risk for inadvertent inoculation and autoinoculation, and is…